v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2020-002458-25-IT |
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002458-25/IT |
First author
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
bosi.emanuele@hsr.it |
Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2020-08-10 |
Recruitment status
Last imported at : Aug. 28, 2021, midnight Source : EU Clinical Trials Register |
Terminated |
Study design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Randomized |
Design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
a. Informed consent signed b. Patients hospitalized with confirmed swab RT-PCR detection of SARS-CoV-2 c. X-ray and/or TC diagnosed pneumonia d. Age >=18 years e. Clinical status defined as 3, 4 or 5 on the 7-point ordinal scale a. Consenso informato firmato b. Pazienti ospedalizzati con tampone nasofaringeo positivo a SARS-CoV-2 confermato tramite test su acido nucleico (RT-PCR) c. Diagnosi di polmonite tramite radiografia tradizionale e/o TC d. Età >=18 anni e. Stato clinico definito come 3, 4, o 5 secondo la scala a sette punti |
Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
a. Known allergy or hypersensitivity to IFNß-1a or IFNß-1b b. Presence of severe concomitant illnesses/medical conditions that in the physician opinion do not allow participation to the stud c. Pregnant or lactating females d. History of major depression disorder or suicidal attempt or suicidal ideation e. Spontaneous blood ALT/AST levels > 5 times the upper limit of normal f. Clinical status defined as 1, 2, or 6 on the 7-point ordinal scale a. Allergia o ipersensibilità nota a IFNß-1a o IFNß-1b. b. Presenza malattie o condizioni mediche concomitanti che secondo l’opinione del medico non permettono l’inclusione c. Gravidanza o allattamento d. Anamnesi indicativa di disturbo depressivo maggiore, tentativo di suicido o ideazione suicidaria e. Livelli basali di ALT o AST cinque volte il limite superiore di normalità. f. Stato clinico definito come 1, 2 o 6 nella scala a sette punti |
Number of arms
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2 |
Funding
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
OSPEDALE SAN RAFFAELE |
Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
100 |
Countries
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Italy |
Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
126 |
primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Time to negative conversion of SARS-CoV-2 nasopharyngeal swab. Viral load will be measured by RT-PCR. Tempo alla negativizzazione per infezione da SARS-CoV-2 nei tamponi nasofaringei. La carica virale viene misurata tramite real-time PCR. |
Notes
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Declared number of arm (2.0) differs from found arms (1.0) |
Phase
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Phase 2 |
Arms
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "", "treatment_id": 671, "treatment_name": "Interferon beta 1a", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |